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Amendment  to  the  proposal  for  a 
COUNCIL  DIRECTIVE 
widening  the  scope of Directives 65/65/EEC  and  75/319/EEC  on  the 
approximation of  the  laws  of  the  Member  States on  medicinal 
products and  laying  down  additional  provisions on 
homeopathic  medicinal  products 
Amendment  to  the  proposal  for  a 
COUNCIL  DIRECTIVE 
SYI\'  251 
widening  the  scope  of  Directive 81/851/EEC  on  the  approximation of 
the  Jaws  of  the Member  States on  veterinary medicinal  products 
and  laying  down  additional  provisions on  homeopathic 
veterinary medicinal  products 
(presented  by  the Commission  pursuant  to Article  149(3) 
of  the  EEC-Treaty) 
SYN  252 - 2  -
EXPLANATORY  MEMORANDUM 
At  its plenary session on  1.3  June  1991,  the  E,uro.pean.Parliament,  on  first  reading 
of  the co-operation procedure.  gave  its opinion upon  two  proposals  for  Directives 
relating to homeopathic  medicines  for  human  and  veterinary use- COM(90)72  of 
22.03~90,  SYN  .251-252. 
The  Commission  has  decided,  In  accordance  with Article  149,  paragraph  3 of  the  EEC 
Treaty,  to amend  Its proposals  in  order  to  incorporate  into  the  text  17  out  of  the 
~8 amendements  adopted  by  the Parliament. 
The  primary  alms  of  the  amendments  accepted  by  the  Commission  are 
-to avoid  the distortion of  competition  between  manufacturers  ...  - ~  .  ·- .. 
-to maintain·the  principl~ of  a  free  choice of  therapies 
-to assimilate anthroposophlc medicines  as  homeopathic  medicines  when  described 
in  an  offical  pharmacopoeia 
-to introduce  appropriate  references  to  homeopathic  and  anthroposophic 
principles. - 3  -
By  contrast,  the Commission  reJected other  amendments  for  three principal  reasons. 
Certain of  the  amendments  go  far  beyond  the  limits of  those  proposals which  deal 
with  the  free  movement  of medicines,  for  example;  training for  and  engaging  In 
professional  practice,  and  the way  In  which  the cost of  medicines  to  the patient 
Is  met  by  public  funding. 
Some  amendments  show  excessive partiality towards  particular medical  traditions, 
bearing  In  mind  that  the Commission  must  remain  neutral  in  the  debate  between 
"conventional"  and  "alternative" medicine. 
Other  amendments  would  widen  excessively  the  scope  of  the  simplified registration 
procedure  (Article 7),  to  the extent  that  a  full  marketing authorization 
(Article 9)  would  become  an  exception  to  the  normal  rule. 
It  is worth  recalling  that  since 1965  throughout  the Community  the  normal  basis 
for  a  marketing authorization has  been  three standard criteria (quality,  safety 
and  efficacy)  leading  the  competent  authorities to undertake  an  evaluation of  the 
risks  and  benefits expected of  the medicament  In  question. - 4  -
However.  the simplified registration procedure,  In  the  formproposed  by  the 
Commission,  constitutes rather  an  administrative notification.  adequate  for 
homeopathic  medicines which  do  not  present  any  known  risk  by  virtue of  their 
method  of  administration  (oral)  and  the  low  concentration of  their active 
constituents.  which  Is  fixed  at  less  than  one  part  per  million.  Manufacturing 
Quality can  be  verified  from  the dossier  supplied. 
The  other  routes of  administration described  by  the pharmacopoeias,  especially 
inJectibles.  or  stronger  concentrations of active  constituents~ can.  In  certain 
cases.  expose  patients to potential  risks and  necessitate because of· this a  more 
comprehensive  authorization procedure  based  upon an  evaluation of  the  risks and 
benefits by  the  competent  authorities  in  accord~nce with  tha pro~i~ions of 
Article 9. "'· 
- 5  -
Amendment  to  the proposal  for  a 
COUNCIL  DIRECTIVE 
widening  the scope of  Directives 65/65/EEC  and  75/319/EEC  on  the 
approximation of  the  laws  of  the Member  States on  medicinal 
products and  laying  down  additional  provisions on 
homeopathic  medicinal  products 
SYN  251 
(Presented by  the Commission  in  accordance  with  article  149, 
paragraph  3 of  EEC  Treaty) 
Original  proposal  Amended  proposal 
Titles and  visas unchanged 
First  recital 
Whereas  differences current.ly existing 
between  the provisions  laid  down  by 
law,  regulation or  administrative 
action  in  the Member  States may  hinder 
trade  in  homeopathic  medicinal 
products within  the  Community; 
Whereas  differences currently existing 
between  the  provisions  laid down  by 
law,  regulation or  administrative 
action  in  the  Member  States may  hJnder 
trade  in  homeopathic  medicinal 
products within  the Community  and  thus 
lead  to discrimination  and  distorslon 
of  competition  between  manufacturers of 
these  products; 
2nd  recital  unchanged 
Recital  2a  (new) 
Whereas  freedom  of  choice with  regard 
to  therapy  needs  to be  safeguarded; 
whereas,  despite considerable dif-
ferences  In  the status of alternative 
medicines  In  the  various Member  States, 
patients should  be  quaranteed  free 
access  to  the  therapy of  their  choice, 
provided all  precautions  are  taken  to 
ensure  the  quality  and  safety of 
products; 
3rd  recital  unchanged .  .~ 
- 6  -
Original  proposal  Amended  proposal 
Fourth  recital 
Whereas  homeopathic  medicine  is 
officially recognized  In  certain 
Member  States but  is only  tolerated 
In  other  Member  States;  whereas, 
therefore,  It  Is appropriate  to 
recognize .certain national  homeopathic 
traditions without  Imposing  them 
throughout  the Community; 
Whereas  homeopathic  medicine  is 
officially recognized  In  certain 
Member  States but  Is only  tolerated 
in  other  Member  States; 
5th,  6th  and  7th  recitals unchanged 
Eighth  recital 
Whereas~ having  regard  to  the 
particular characteristics of  these 
medicinal  products,  such  as  their 
very  low  content of  active principles 
and  the difficulty of  applying  to them 
the  conventional  statistical  methods 
relating  to cl lnlcal  trials,  it  is 
appropriate  to provide  a  simplified 
registration system  for  those 
traditional  homeopathic  medicinal 
products which  are  placed on  the  market 
without  specific therapeutic 
indications  In  a  preparation which 
does  not  present  a  risk  for  the  patl~nt; 
Whereas.  having  regard  to  the 
particular characteristics of  these 
medicinal  products,  such  as their· 
very  low  content  of  active principles 
and  the difficulty of  applying  to  them 
the  conventional  statistical  methods 
relating  to clinical  trials,  it  is 
appropriate  to provide a  simplified 
registration system  for  those 
traditional  homeopathic  medicinal 
products which  are  placed on  the  market 
without  specific therapeutic 
Indications  In  a  preparation and  dosage 
which  does  not  present  a  risk  for  the 
pat l.ent; 
9th  recital  unchanged - 7  -
Original  proposal  Amended  proposal 
Article 1 
For  the  purposes of  this Directive 
"homeopathic  medicinal  product"  shall 
mean  any  medicinal  product  prepared  In 
accordance  with  a  homeopathic  manufac-
turing  procedure  described  by  the 
European  Pharmacopoeia.  or  In  the 
absence  thereof.  by  the official 
pharmacopoeia  of  a  Member  State. 
Homeopathic  preparations  are 
produced  from  products.  substances 
or  compositions  called homeopathic 
stocks  by  successive dilutions. 
For  the  purposes of  this Directive 
"homeopathic  medicinal  product"  shal I 
mean  any  pharmaceutical  preparation 
prepared  In  accordance  with  a 
homeopathic  manufacturing  procedure 
described  by  the  European 
Pharmacopoeia.  or  In  the absence 
thereof.  by  the official  pharmacopoeia 
of  a  Member  State. 
For  the  purposes of  this Directive 
anthroposophical  medicinal  products 
described  by  an  official  pharmacopoeia 
shall  be  treated as equivalent  to 
homeopathic  medicinal  products. 
Homeopathic  preparations  are produced 
from  products,  substances or  composi-
tions  cal led  homeopathic  stocks  by 
successive dilutions and  potentiation. 
A homeopathic  medicinal  product  may 
also contain a  member  of  different 
components. 
A homeopathic  preparation may  contain. 
with  the exception of  catalysts,  only 
homeopathic  stocks  in  a  minimum 
dilution of  1:10. 
Articles  2.  3.  4,  5  and  6  unchanged 
Article 7,  paragraph  1  unchanged 
Article 7  (2) 
Seventh  Indent  a  (new) 
- a  sentence advising  the user  to 
consult  a  competent  therapist  whilst 
using  the medicinal  product  if  the 
If  the  symptoms  persist. 
Rest  of  the article unchanged - 8  -
Original  proposal  Amended  proposal 
Article 8,  introductory  phrase  and  first  three  indents 
An  application  for  a  simplified 
registration submitted by  the  person 
responsible  for  marketing may  cover 
a  series of  preparations derived  from 
the  same  homeopathic  stock.  The 
following  documents  shall  be  included 
with  the application  in  order  to 
demonstrate,  in  particular,  the 
pharmaceutical  quality and  the  batch 
consi~tency of  the  products concerned 
-scientific name  of  the  homeopathic 
stock,  together  with  a  mention  of 
the  various  routes of  administra-
tion,  pharmaceutical  forms  and 
dilutions  to be  registered; 
-dossier describing  how  the 
homeopathic  stock  is obtained and 
controlled,  and  Justifying  its 
homeopathic  nature,  on  the basis 
of  an  adequate  homeopathic  bib I io-
graphy; 
-manufacturing and  control  file 
for  each  pharmaceutical  form  and 
a  description of  the  method  of 
dilution; 
Anappl ication for  a  simplified 
registration submitted by  the  person 
responsible  for  marketing may  cover 
a  series of  preparations derived  from 
the  same  homeopathic  stock or  stocks. 
The  following  documents  shall  be 
included  with  the  application  in  order 
to demonstrate,  in  particular,  the 
pharmaceutical  quality.and  the  batch 
consistency of  the  products concerned 
-scientific name  of  the  homeopathic 
stock  ~r stocks,  together  with  a 
mention  of  the  various  routes of 
admin~stration,  pharmaceutical  forms 
and  strengths  to  be  registered; 
-dossier describing  how  the 
homeopathic  stock  or  stocks  is/are 
obtained and  controlled,  and 
justifying  its homeopathic  nature, 
on  the  basis of  an  adequate  homeopa-
thic or  anthroposophical  bibl io-
graphy; 
-manufacturing and  control  file 
for  each  pharmaceutical  form  and 
a  description of  the method  of 
dilution and  potentiation; 
Rest  of  the article unchanged - 9  -
Original  proposal  Amended  proposal 
Art I  c I  e  9  ( 1) 
1.  Homeopathic  medicinal  products 
other  than  those  referred  to  In 
Article 7  shal I  be  authorized and 
labelled  In  accordance with  the 
provisions of Articles 5  to  21  of 
Directive 65/65/EEC  and  Articles 1 
to 7  of  Directive 75/319/EEC. 
including  the  provisions  concerning 
proof of  therapeutic effect. 
1.  Homeopathic  and  antroposophlcal 
medicinal  products other  than  those 
referred  to  In  Article 7  shall  be 
authorized  and  label led  pursuant  to 
the provisions of Articles 5  to  21  of 
Directive 65/65/EEC  and  Articles 1 
to 7  of  Directive 75/319/EEC. 
Including  the  provisions  concerning 
proof of  therapeutic  effect~ 
accordance with  the  basic principles 
and  special  nature of  homeopathic  or 
anthroposophical  medicine. 
Article 9(2)  unchanged 
Artlele 10  (1)  and  (2)  unchanged 
Article 10  (3)  (new) 
3.  Not  later  than  31  December  1995  the 
Commission  shal I  present  a  report  to 
the  Councl I  and  to  the  European 
Parliament  concerning  the operation of 
this Directive. 
Article  11  unchanged - 10  -
Amendment  to  the  proposal  for  a 
COUNCIL  DIRECTIVE 
widening  the  scope  of  Directive 81/851/EEC  on  the  approximation of 
the  laws  of  the Member  States on  veterinary medicinal  products 
and  laying. down  additional  provisions on  homeopathic 
veterinary medicinal  products 
(presented  by  the Commission  in  accordance  with  Article 149, 
paragraph  3 of  the EEC  Treaty) 
Original  proposal 
Whereas  differences currently 
Amended  proposal 
First  recital 
Whereas  differences curren.lty 
SYN  252 
existing between  the  provisions  laid 
down  by  law,  regulation or  administra-
tive action  by  the  Member  States may 
hinder  trade  In  homeopathic  medicinal 
products within  the  Community; 
existing between  the  provisions  laid 
down  by  law,  regulation or  administra-
tive action  in  the  Member  States may 
hinder  tiade  in  homeopathic  medicinal 
products within  the  Community  and  thus 
lead  to discrimination and  distorsion 
of  competition  between  manufacturers of 
. these  products; 
2nd  recital  unchanged 
Recital  2a  (new) 
Whereas  freedom  of  choice with 
regard  to  therapy  needs  to be 
safequarded; 
3rd  recital  unchanged 
Fourth  recital 
Whereas  homeopathic  medicine  is 
officially recognized  in  certain 
Member  States but  is only  tolerated 
in  other  Member  States;  whereas, 
therefore,  It  Is  appropriate  to 
recognize  certain national  homeopathic 
.~  . 
traditions without  imposing  them 
throughout  the Community; 
Whereas  homeopathic  medicine  is 
officially  recognized  in  certain 
Member  States but  is only  tolerated 
in  other  Member  States; 
5th,  6th and  7th  recitals unchanged - 11  -
Original  proposal  Amended  proposal 
Eighth  recital 
Whereas,  having  regard  to  the 
particular characteristics of  these 
medicinal  products,  such  as  their 
very  low  content  of  active principles 
and  the difficulty of  applying  to  them 
the  conventional  statistical  methods 
relating  to clinical  trials,  it  is 
appropriate  to provide  a  simplified 
registration system  for  those 
traditional  homeopathic  veterinary 
medicinal  products which  are  placed 
on  the market  without  specific 
therapeutic  indications  in  a 
preparation which  does  not  present 
a  risk  for  the  animal  or  the  consumer 
of  animal  products; 
Whereas,  having  regard  to  the 
particular characteristics of  these 
medicinal  products,  such  as  their 
very  low  content of active principles 
and  the difficulty of  applying  to  them 
the  conventional  statistical  methods 
relating  to clinical  trials,  It  is 
appropriate  to provide a  simplified 
registration system  for  those 
traditional  homeopathic  veterinary 
medicinal  products which  are  placed 
on  the market  without  specific 
therapeutic  indications  In  a 
preparation  and  dosage  which  does  not 
present  a  risk  for  the  animal  or  the 
consumer  of  animal  products; 
9th  recital  unchanged 
Article  1 
For  the  purposes of  this Directive 
"homeopathic  veterinary medicinal 
product"  shall  mean  any  veterinary 
medicinal  product  prepared  in 
accordance  with  a  homeopathic 
manufacturing  procedure  described  by 
the  European  Pharmacopoeia,  or  in 
the  absence  thereof,  by  the official 
pharmacoposia  of  a  Member  State. 
Homeopathic  preparations are  produced 
from  products,  substances or 
compositions  called homeopathic  stocks 
by  successive dilutions. 
For  the  purposes of  this Directive 
"homeopathic  veterinary medicinal 
product"  shall  mean  any  pharmaceutical 
preparation prepared  in  accordance  with 
a  homeopathic  manufacturing  procedure 
described  by  the  European 
Pharmacopoeia,  or  in  the  absence 
thereof,  by  the official  pharmacopoeia 
of  a  Member  State. 
Homeopathic  preparations are  produced 
from  products,  substances or 
compositions  cal led  homeopathic  stocks 
by  successive dilutions  and 
potentiation.  A homeopathic  medicinal 
product  may  also contain  a  number  of 
different  components. - 12  -
Homeopathic  preparations may  contain, 
with  the  exception of catalysts,  only 
homeopathic  stocks,  In  a  minimum  of 
1:10. 
Articles 2,  3,  4,  5, t  and  7  unchanged 
Original  proposal  Amended  proposal 
Article 8 
An  application  for  a  simplified 
registration submitted  by  the person 
responsible  for  marketing  may  cover 
a  series of  preparations derived  from 
the  same  homeopathic  stock.  The 
following  documents  shal I  be  included 
with  the application  In  order  to 
demonstrate,  in  particular,  the 
pharmaceutical  quality and  the  batch 
to batch  consistency of the  products 
concerned  : 
-scientific name  of  the  homeopathic 
stock,  together  with  a  mention of 
the  various  routes of  administration, 
pharmaceutical  forms  and  di lutlons 
to be  registered; 
-dossier described  how  the stock  Is 
obtained and  controlled,  and 
Justifying  Its homeopathic  nature, 
on  the  basis of  an  adequate 
homeopathic  bibliography; 
An  application  for  a  simplified 
registration submitted by  the  person 
responsible  for  marketing  may  cover 
a  series of  preparations derived  from 
the  same  homeopathic  stock or  stocks. 
The  foi lowing  documents  shal 1 be 
included with  the application  in  order 
to demonstrate,  in  particular,  the 
pharmaceutical  quality and  the  batch 
to batch  consistency of  the  products 
concerned  : 
-scientific name  of  the  homeopathic 
stock or  stocks~  together  with  a 
mention of  the  various  routes of 
administration,  pharmaceutical  forms 
and  strengths  to  be  registered; 
-dossier describing  how  the 
homeopathic  stock/stocks  is/are 
obtained  and  control led,  and 
justifying  its/their  homeopathic 
nature,  on  the basis of  an 
adequate  homeopathic  bibliography; -manufacturing and  control  file 
for  each  pharmaceutical  form  and 
a  description of  the method  of 
dilution; 
-manufacturing authorization for 
the  preparations concerned; 
-copies of  any  registrations or 
authorizations obtained  for  the 
same  preparations  in  other  Member 
States; 
- one  or  more  specimens  or  mock-ups 
of  the sales presentation of  the 
preparations  to  be  registered. 
- 13  -
-manufacturing and  control  file 
for  each  pharmaceutical  form  and 
a  description of  the method  of 
dilution and  potentiation; 
-manufacturing authorization  for 
the  preparations concerned; 
-copies of  any  registrations or 
authorizations obtained  for  the 
same  preparations  In  other  Member 
States; 
- one  or  more  specimens  or  mock-ups 
of  the sales presentation of  the 
preparations  to be  registered; 
- documents  quaranteelng  the safety 
of  the  preparation and,  In  the case 
of  veterinary medicinal  products 
Intended  for  administration  to  food-
producing  animals,  quaranteeing  the 
absence  of  harmful  residues. Original  proposal 
Homeopathic  veterinary medicinal 
products qther  than  those  referred 
to  In  Article 7  shal I  be  authorized 
and  labelled  In  accordance with  the 
provisions of Articles 5  to  15  of 
Directive 81/851/EEC,  including  the 
provisions concerning proof of 
therapeutic effect,  and  shall  be 
label led  In  accordance with  the 
provisions of Articles 43  to 50  of 
Directive 81/851/EEC. 
- 14  -
Amended  proposal 
Article 9 
Homeopathic  veterinary medicinal 
products other  than  those  referred 
to  In  Article 7  shall  be  authorized 
and  labelled  In  accordance with  the 
provisions of Articles 5  to 15  of 
Directive 81/851/EEC,  including  the 
provisions concerning  proof of 
therapeutic effect,  and  shall  be 
label led  pursuant  to  the  provisions 
of  Articles 43  to 50  of  Directive 
81/851/EEC,  in  accordance with  the 
basic principles and  special  nature 
of  homeopathic  or  anthroposophlcal 
medicine. 
Article 10,  paragraphs  1 and  2 unchanged 
Article  10  (3)  (new) 
~ 
3.  Not  later  than  31  December  1995 
the Commission  shal I  present  a 
report  to the Counci I  and  to  the 
European  Pari lament  concerning 
.the operation of  this Directive. 
Article  11  unchanged 
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